An anonymous director reports

ADASTRA HOLDINGS LTD. APPOINTS NEW DIRECTOR

Adastra Holdings Ltd. has appointed Calum Maschi as a director of the company in place of Jonathan Edwards who has resigned as a director, effective April 30, 2026.

Mr. Maschi is a construction professional with over 15 years of experience across large-scale industrial, institutional and infrastructure projects, including management roles on major projects such as LNG Canada.

The company would like to thank Mr. Edwards for his contributions to the company and wishes him success in his future endeavours.

About Adastra Holdings Ltd.

Adastra has become one of Canada's leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves non-medical and medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are now well established with a growing distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with health care professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients.